4.8 Article

DNA Nanomachines for Identifying Cancer Biomarkers in Body Fluids and Cells

Journal

ANALYTICAL CHEMISTRY
Volume 93, Issue 4, Pages 1855-1865

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c03518

Keywords

-

Funding

  1. Beijing Advanced Innovation Center for Biomedical Engineering and Beihang University

Ask authors/readers for more resources

DNA nanomachines, designable and switchable nanostructures made of DNA, have great potential for early detection of cancer biomarkers with advantages of noninvasiveness, affordability, high sensitivity, and high specificity. This summary highlights recent DNA nanomachine-based platforms for detecting cancer biomarkers, both from body fluids and in cells.
Identifying molecular biomarkers promises to significantly improve the accuracy in cancer diagnosis at its early stage. DNA nanomachines, which are designable and switchable nanostructures made of DNA, show broad potential to detect tumor biomarkers with noninvasive, inexpensive, highly sensitive, and highly specific advantages. This Feature summarizes the recent DNA nanomachine-based platforms for the early detection of cancer biomarkers, both from body fluids and in cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available